Back to all tests

Natera

Natera Hereditary Cancer Screening

$250
8.6/10
8.6/10

Spanwise Verdict

Natera is a leading clinical genetics company whose tests are used by healthcare providers nationwide. Their hereditary cancer panels screen for mutations in genes associated with breast, ovarian, colorectal, pancreatic, and other cancers. Unlike consumer tests, Natera's clinical-grade sequencing is the same quality used for medical decision-making, and results can be shared directly with your physician for care planning.

Best for:Hereditary cancer riskFamily history of cancerBRCA testing

Overview

Clinical-grade hereditary cancer genetic testing that screens for mutations in genes like BRCA1, BRCA2, and dozens of other cancer predisposition genes — the same tests ordered by oncologists.

Pros

  • Clinical-grade testing — same quality as hospital genetics labs
  • Comprehensive panels covering 30+ cancer predisposition genes
  • Results accepted by physicians for medical decision-making
  • Includes BRCA1, BRCA2, Lynch syndrome genes, and more
  • Genetic counseling support included

Cons

  • Focused on cancer genes — not a comprehensive genetic health test
  • May require physician order depending on state regulations
  • Positive results may have insurance implications
  • Does not include pharmacogenomics or other genetic insights
Visit Natera